• 0
MENU
Cart Details

Granocyte 34 Powder for Injection

  • Home
  • Granocyte 34 Powder for Injection

Product Informations: Granocyte 34 Powder for Injection

In Prevention of Infections after chemotherapy Granocyte 34 Powder for Injection increases the production of white blood cells by stimulating the immune system in our body. White blood cells are those cells that help us to fight infections. This medicine is really effective and must be used under medical supervision. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.

Your doctor or nurse will give you this medicine. Kindly do not self administer.
Granocyte 34 Powder for Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections. Granocyte 34 Powder for Injection is given as an injection by a qualified medical professional. You should continue to take as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. You might be asked for regular tests done to check the number of blood cells in your blood and your bone density level while you are taking this medicine. The most common side effects of this medicine include pains in your bones, muscles, joints, back, and extremities (legs and arms), a headache, fever, nausea, weakness, increased liver enzymes, and high or low platelets count. Other than this, pain or redness at the site of injection may also occur. It might not prevent you from all kinds of infection, hence inform your doctor if you notice fever, chills, shortness of breath, sore throat, and swelling around the face or neck. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You must avoid driving or attention-seeking activity if you experience dizziness after taking this medicine.
  • Joint pain
  • Back pain
  • Pain in extremities
  • Headache
  • Fever
  • Nausea
  • Weakness
  • Increased white blood cell count
  • Low blood platelets
  • Increased liver enzymes
Alcohol : CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Granocyte 34 Powder for Injection. Please consult your doctor.

Pregnancy : CONSULT YOUR DOCTOR

Granocyte 34 Powder for Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life

threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breast feeding : SAFE IF PRESCRIBED

Granocyte 34 Powder for Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving : CONSULT YOUR DOCTOR

It is not known whether Granocyte 34 Powder for Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney : CONSULT YOUR DOCTOR

There is limited information available on the use of Granocyte 34 Powder for Injection in patients with kidney disease. Please consult your doctor.

Liver : CONSULT YOUR DOCTOR

There is limited information available on the use of Granocyte 34 Powder for Injection in patients with liver disease. Please consult your doctor.

If you miss a dose of Granocyte 34 Powder for Injection, please consult your doctor.

Chemical Class::Granulocyte Colony-Stimulating Factor|Habit Forming::No|Therapeutic Class::ANTI NEOPLASTICS|Action Class::Granulocyte-colony stimulating factor (G-CSF)

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra


Alternatives and Substitutes


Customer Reviews

No customer reviews yet.

References

FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More

European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More

ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More

Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More


All Substitutes Product.


Available options.

Same salt composition: Lenograstim (33.6MIU)

Test Buy medical disposable face mask
to protect your loved ones